INTERNATIONAL PATENT: PARAGON THERAPEUTICS, INC., VIRIDIAN THERAPEUTICS, INC. FILES APPLICATION FOR "FCRN ANTAGONISTS WITH IMPROVED HALF-LIFE AND METHODS OF USE"

GENEVA, April 30 -- PARAGON THERAPEUTICS, INC. (221 Crescent StreetBuilding 23, Suite 105Waltham, Massachusetts 02453), VIRIDIAN THERAPEUTICS, INC. (221 Crescent Street, Suite 103AWaltham, Massachusetts 02453) filed a patent application (PCT/US2024/051639) for "FCRN ANTAGONISTS WITH IMPROVED HALF-LIFE AND METHODS OF USE" on Oct 16, 2024. With publication no. WO/2025/085553, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Yuqi (221 Crescent StreetBuilding 23, Suite 105Waltham, Massachusetts 02453), OH, Jason Z. (221 C...